Estadístiques de Assessment of a new ROS1 immunohistochemistry clone (SP384) for the identification of ROS1 rearrangements in patients with non-small cell lung carcinoma: the ROSING study
Visites totals
views | |
---|---|
Assessment of a new ROS1 immunohistochemistry clone (SP384) for the identification of ROS1 rearrangements in patients with non-small cell lung carcinoma: the ROSING study | 95 |
Visites totals per mes
views | |
---|---|
October 2024 | 0 |
November 2024 | 0 |
December 2024 | 0 |
January 2025 | 0 |
February 2025 | 2 |
March 2025 | 0 |
April 2025 | 0 |
Visites al fitxer
views | |
---|---|
conde-jto-asse.pdf(legacy) | 130 |
conde-jto-asse.pdf | 40 |
Vistes principals per país
views | |
---|---|
United States | 48 |
Spain | 12 |
Belgium | 8 |
Germany | 7 |
Sweden | 5 |
China | 3 |
France | 2 |
Ireland | 2 |
Canada | 1 |
Czechia | 1 |
India | 1 |
Iran | 1 |
Japan | 1 |
Macedonia | 1 |
Taiwan | 1 |
Visites principals per ciutat
views | |
---|---|
San Ramon | 10 |
Madrid | 8 |
Mountain View | 8 |
Ashburn | 5 |
Cambridge | 4 |
Menlo Park | 3 |
Shenzhen | 3 |
Ann Arbor | 2 |
Boardman | 2 |
Cupertino | 2 |
Durham | 2 |
Fairfield | 2 |
Barcelona | 1 |
Bitola | 1 |
Dearborn | 1 |
Dublin | 1 |
Garching | 1 |
Indianapolis | 1 |
Rochester | 1 |
San Diego | 1 |
Seattle | 1 |
Toronto | 1 |
Uwajima | 1 |
Villena | 1 |